ClinicalTrials.Veeva

Menu

Salvage of Infected Cardiovascular Implantable Electronic Devices (CIED) by Localized High-dose Antibiotics

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Infection

Treatments

Drug: CITA-RNPT
Procedure: Extraction of infected CIED

Study type

Interventional

Funder types

Other

Identifiers

NCT01770067
0093-12-HYMC

Details and patient eligibility

About

Following previous positive experience with regulated CITA-RNPT of infected CIEDs, we suggest increasing the number of recruited patients and that CITA-RNPT can be administered prophylactically to patients prior to replacement of previously treated CIEDs, immuno-compromised patients, and others.

Enrollment

100 estimated patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • High-risk patients for CIED infections
  • CIED infections

Exclusion criteria

  • Systematic infection

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Infected CIED and Infection-Prone Patients Prior to CIED Implantation
Experimental group
Description:
Administration of high-dose antibiotics (CITA)
Treatment:
Drug: CITA-RNPT
Infected CIED extraction
Active Comparator group
Description:
Extraction of infected CIED
Treatment:
Procedure: Extraction of infected CIED

Trial contacts and locations

1

Loading...

Central trial contact

Moris Topaz, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems